Safety Study of MGA271 in Refractory Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Prostate Cancer|Melanoma|Renal Cell Carcinoma|Triple-negative Breast Cancer|Head and Neck Cancer|Bladder Cancer|Non-small Cell Lung Cancer
Interventions: BIOLOGICAL: MGA271
Sponsor: MacroGenics